U.S. Wireless Telecom Stock News

NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly PsA Trial Links Dual Therapy Success With Valuation Upside Potential

Eli Lilly (NYSE:LLY) reported Phase 3b TOGETHER-PsA data showing that Taltz combined with Zepbound outperformed Taltz alone in adults with both active psoriatic arthritis and obesity. The trial represents the first time a dual-targeted approach has shown efficacy in this comorbid population, linking an immunology therapy with a metabolic drug in one regimen. The findings create a potential path toward label expansion for both medicines and may influence future treatment standards for...
NYSE:BMY
NYSE:BMYPharmaceuticals

A Look At Bristol Myers Squibb (BMY) Valuation As Growth Portfolio Outperforms Recent GAAP Loss

Why Bristol-Myers Squibb (BMY) is on investors’ radar Bristol-Myers Squibb (BMY) is drawing attention after recent share price moves, with the stock showing a mix of short term pressure and longer term resilience that invites a closer look at its fundamentals. See our latest analysis for Bristol-Myers Squibb. At a share price of US$58.54, Bristol-Myers Squibb has seen a 1 day share price decline of about 1.5%, alongside a 9.5% year to date share price return and a 12.6% five year total...
NYSE:ETR
NYSE:ETRElectric Utilities

Why Entergy (ETR) Is Up 10.0% After Meta Funds Its Louisiana Grid Expansion Plan

Earlier this month, Entergy Louisiana disclosed a major agreement under which Meta Platforms will finance ten natural gas plants, around 240 miles of high-voltage transmission lines, grid-scale battery storage, and nuclear uprates to power Meta’s Hyperion data center in rural Louisiana while covering its full cost of service. The deal’s structure, which is expected to deliver more than US$2.00 billion in ratepayer savings over two decades, highlights how tailored utility-customer...
OTCPK:KISB
OTCPK:KISBBanks

Kish Bancorp (OTCPK:KISB) Net Profit Margin Near 26% Reinforces Bullish Community Narratives

Kish Bancorp (KISB) just turned in its FY 2025 numbers with fourth quarter revenue of US$18.9 million and basic EPS of US$1.84, alongside trailing twelve month revenue of US$70.3 million and EPS of US$6.25 that frame the full year picture. Over the past few quarters, revenue has moved from US$15.8 million in Q3 2024 to US$18.9 million in Q4 2025, while quarterly EPS has gone from about US$1.39 to US$1.84. This sets up a results season where margins and earnings quality are front and center...
NYSE:COMP
NYSE:COMPReal Estate

Compass (COMP) Valuation Check After Recent Share Price Weakness

Compass (COMP) has been drawing fresh attention after recent trading left the stock with a year-to-date return of about a 33% decline and a past 3-month move of roughly a 34% decline. See our latest analysis for Compass. The recent 1-day share price return of a 7.09% decline and 30-day share price return of a 27.38% decline at a latest share price of $7.08 sit against a 3-year total shareholder return of 119.20%, which hints that recent momentum has faded compared with earlier gains. If...
NYSE:UWMC
NYSE:UWMCDiversified Financial

UWM Holdings Tests Governance Stance With Bid For Two Harbors Servicing

UWM Holdings (NYSE:UWMC) has publicly challenged the management and board of Two Harbors as part of its acquisition proposal. The company is openly criticizing how Two Harbors is overseen, while outlining its interest in the firm's mortgage servicing portfolio. This move highlights UWM Holdings' acquisition ambitions and puts its leadership approach and governance views in the spotlight. For readers watching NYSE:UWMC, this public challenge comes at a time when the stock trades at $3.42 and...
NYSE:PBT
NYSE:PBTOil and Gas

Permian Basin Royalty Trust (PBT) Net Margin Compression Tests Bullish Narratives

Permian Basin Royalty Trust FY 2025 Earnings Snapshot Permian Basin Royalty Trust (PBT) has put up a mixed set of numbers for FY 2025 so far, with third quarter revenue at US$7.3 million and basic EPS of US$0.15, compared with US$8.4 million of revenue and EPS of US$0.17 in the same quarter a year earlier. Across the last six reported quarters, revenue has ranged from roughly US$3.1 million to US$8.8 million, while quarterly EPS has moved between US$0.05 and US$0.18. This gives a clear view...
NasdaqGM:DAVE
NasdaqGM:DAVEConsumer Finance

Assessing Whether Dave (DAVE) Shares Look Undervalued After Recent Volatility

Event context and recent share performance Dave (DAVE) has drawn investor attention after recent trading, with the stock last closing at US$174.95. The shares show a 2.3% decline over the past day and a 16.6% decline over the past week. See our latest analysis for Dave. While the recent 1-week share price return of a 16.6% decline and 90-day share price return of a 23.2% decline point to fading short term momentum, the 1-year total shareholder return of 106.9% and very large 3-year total...
NYSE:WCN
NYSE:WCNCommercial Services

Evaluating Waste Connections (WCN) Valuation After Recent Share Price Weakness

Why Waste Connections (WCN) Is On Investors’ Radar Recent share weakness in Waste Connections (WCN), including double digit negative returns over the past month and past 3 months, has turned more attention to whether the current price reflects its underlying fundamentals. See our latest analysis for Waste Connections. At a share price of US$156.02, Waste Connections has faced steady selling pressure recently, with a 30 day share price return of 9.36% and year to date share price return of...
NasdaqGS:TXN
NasdaqGS:TXNSemiconductor

TI’s New 800V AI Data Center Power Platform Might Change The Case For Investing In Texas Instruments (TXN)

Earlier this month, Texas Instruments introduced new IsoShield-based isolated power modules and an 800V DC power architecture for AI data centers, aimed at boosting power density, efficiency and safety in applications from EVs to next-generation computing. By tightly integrating transformers and power stages and showcasing designs alongside NVIDIA’s 800V reference platform, TI is underscoring its role in the power infrastructure underpinning AI data centers, advanced automotive systems and...
NYSE:JPM
NYSE:JPMBanks

Is It Time To Reconsider JPMorgan Chase (JPM) After Recent Share Price Weakness?

If you are trying to work out whether JPMorgan Chase at about US$282.84 is offering good value or asking too much, it helps to break the story into what the market has been pricing in and what the fundamentals might support. The stock has seen a 1.3% decline over the last 7 days and a 5.8% decline over the last 30 days, while still showing a 13.1% decline year to date and an 18.9% return over the last year, with very large gains over 3 and 5 years of 133.0% and 109.0% respectively. Recent...
NasdaqGM:SIGA
NasdaqGM:SIGAPharmaceuticals

Does SIGA (SIGA)’s Repeat Special Dividend Reveal a Deeper Shift in Its Capital Allocation Priorities?

SIGA Technologies, Inc. recently announced that its board declared a special cash dividend of US$0.60 per share, payable on April 23, 2026, to shareholders of record as of April 7, 2026. The company linked this repeat special dividend to its strong balance sheet and its ongoing work with governments on smallpox preparedness amid geopolitical volatility. We’ll now examine how this repeat US$0.60 special dividend and the company’s emphasis on balance sheet strength shape SIGA’s investment...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

Is It Too Late To Consider IDEAYA Biosciences (IDYA) After Its Strong Multi Year Run

If you are wondering whether IDEAYA Biosciences at around US$30.46 is still offering value after a strong run, the key is to separate story from price. The stock has returned 78.7% over the past year and 121.8% over three years, even though the year to date move is a 10.0% decline, with 7 day and 30 day returns of 7.0% and 5.4% declines. Recent coverage has focused on IDEAYA Biosciences as a biotech name that has already delivered strong multi year gains while still experiencing short term...
NYSE:AFL
NYSE:AFLInsurance

A Look At Aflac (NYSE:AFL) Valuation After New Long Term Care Rider And Distribution Collaboration

Aflac (AFL) has drawn fresh attention after adding a long term care rider to its Group Life Term to 120 policy, aligning its product lineup with rising care needs among aging Americans. See our latest analysis for Aflac. Despite the new long term care rider and recent governance debates around separating the CEO and chair roles, Aflac’s 30 day share price return of a 5.8% decline and year to date share price return of a 3.5% decline contrast with a much stronger 3 year total shareholder...
NYSE:MC
NYSE:MCCapital Markets

Assessing Moelis (MC) Valuation After Recent Share Price Weakness

Moelis stock reaction and recent performance snapshot With no single headline event driving Moelis (MC) today, the current share price around US$54.28 and recent performance provide a reference point for thinking about risk, return, and timing. Over the past month the stock shows a return of about a 9% decline, with the past 3 months closer to a 24% decline, while the 1 year total return is roughly a 2% decline. Over the longer term, 3 year and 5 year total returns of about 62% and 31%...
NYSE:AXP
NYSE:AXPConsumer Finance

American Express Shareholder Votes Test Policies And Perceived Valuation Discount

American Express (NYSE:AXP) is set to face several shareholder proposals on political and healthcare policies at its upcoming annual meeting. Proposals call for oversight of political bias risk and for reporting and evaluation of the company’s coverage of transgender healthcare treatments for minors. The board has recommended that shareholders vote against these proposals, bringing governance and social policy questions into focus for investors. American Express, a major player in payments,...
NasdaqGS:TENB
NasdaqGS:TENBSoftware

Can Tenable (TENB) Turn Hexa AI Into a Durable Edge in Unified Exposure Management?

Earlier this month, Tenable Holdings unveiled Tenable Hexa AI, an agentic AI engine within the Tenable One Exposure Management Platform that automates security workflows across IT, cloud, identity, OT and AI environments, now in private customer and partner preview with broader availability expected later in 2026. By using its Exposure Data Fabric to understand how vulnerabilities, identities, assets, configurations and AI systems interact, Hexa AI aims to prioritize what matters most and...
NasdaqGS:ADBE
NasdaqGS:ADBESoftware

Can Adobe’s NVIDIA AI Alliance Redefine Its Creative Edge and Moat In a Crowded Market (ADBE)?

Earlier in March, Adobe and NVIDIA announced a wide-ranging AI partnership that links Adobe’s Firefly models and creative workflows with NVIDIA’s accelerated computing, open models and Omniverse-based 3D digital twin technology. This collaboration aims to embed NVIDIA’s AI infrastructure across products like Photoshop, Premiere Pro, Acrobat and Frame.io, while enabling brand-safe, customizable Firefly models and cloud-native 3D twins for large enterprise content pipelines. We’ll now examine...
NYSE:LAD
NYSE:LADSpecialty Retail

Service Expansion and UK Push Could Be A Game Changer For Lithia Motors (LAD)

In recent months, Lithia Motors has continued expanding its higher-margin service, parts, and in-house lending operations across the US, UK, and Canada, while maintaining solid free cash flow and disciplined capital deployment. Hedge fund backing, stronger UK service and parts margins after the Pendragon acquisition, and rapid growth at Driveway Finance Corporation highlight growing confidence in Lithia’s recurring revenue model and operational systems. We’ll now examine how Lithia’s...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Is It Time To Reconsider Ultragenyx Pharmaceutical (RARE) After Its Prolonged Share Price Slump?

Wondering whether Ultragenyx Pharmaceutical at around US$19.38 is a bargain or a value trap? This breakdown will help you see what the current price is actually offering you. The stock has had a tough run, with returns of a 2.5% decline over 7 days, 17.1% decline over 30 days, 17.9% decline year to date, 48.8% decline over 1 year, and 51.7% and 82.9% declines over 3 and 5 years, which naturally raises questions about how the market is now viewing its prospects and risk. Recent share price...
NYSE:BCO
NYSE:BCOCommercial Services

Is It Time To Revisit Brink's (BCO) After Recent Share Price Weakness

If you are wondering whether Brink's share price matches its underlying worth, this article breaks down what the current valuation really implies for you as an investor. Brink's last closed at US$100.77, with returns of 3.2% over 7 days, a 13.7% decline over 30 days, a 13.5% decline year to date, and a 16.8% gain over 1 year, which may have shifted how the market is thinking about its risk and reward profile. Recent coverage of Brink's has focused on its position in the Commercial Services...
NYSE:DFIN
NYSE:DFINCapital Markets

Assessing Donnelley Financial Solutions (DFIN) Valuation After Recent Share Pullback And Software Growth Expectations

Event context and recent share performance Donnelley Financial Solutions (DFIN) has drawn attention after a recent share move, with the stock closing at US$45.76. That level sits against a recent 8% decline over the past month and a smaller pullback over the past 3 months. See our latest analysis for Donnelley Financial Solutions. That recent pullback comes after a relatively flat year to date share price return of 0.28% and a 5 year total shareholder return of 57.63%. This suggests shorter...
NYSE:ENS
NYSE:ENSElectrical

Is It Too Late To Consider EnerSys (ENS) After An 86% One Year Share Price Rise

If you are wondering whether EnerSys at around US$171 per share is still reasonably priced or already stretched, a closer look at its valuation metrics can help clarify where it might sit on your watchlist. The stock has posted returns of 3.6% over the last 7 days, 3.1% over the past month, 13.7% year to date and 85.6% over the past year, with a 3 year return of 102.6% and 5 year return of 91.3% that many investors are weighing against the current price. Recent coverage of EnerSys has...
NasdaqGS:KHC
NasdaqGS:KHCFood

Is Kraft Heinz (KHC) Now An Opportunity After A 22.5% One Year Share Price Decline?

If you are wondering whether Kraft Heinz at around US$22.04 is a bargain or a value trap, you are not alone. The answer comes down to how you look at its valuation. The share price has moved 2.2% over the last 7 days, while returns over 30 days, year to date and the last year, at 10.4%, 9.6% and 22.5% declines, show that sentiment has been under pressure. Recent coverage has focused on how Kraft Heinz fits into the broader packaged food sector and how investors are weighing consumer brands...